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httpIntroduction: The optimal treatment of in-stent restenosis (ISR) is not determined. We describe the efﬁcacy of
carotid endarterectomy (CEA) with stent removal in the management of symptomatic ISR.
Methods: A 72-year-old man presented with recurrent right limb weakness 8 months after carotid artery
stenting. Digital substraction angiography showed severe ISR (almost 99%). CEA with stent removal was
performed.
Results: A total of 41 cases was reviewed: periarterial inﬂammation was shown in 10.3% of patients; 92.9% had
clear intimaemedia plane; and 85.4% had a good outcome. All patients remained stable at follow-up.
Discussion: CEA with stent removal appears to be a safe, feasible, effective, and durable therapeutic option.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Carotid artery stenting (CAS) has emerged as an alternative
to carotid endarterectomy (CEA) for the treatment of ca-
rotid obstructive disease in the prevention of stroke,
particularly in patients at high surgical risk.1 However, the
rate of in-stent restenosis (ISR) after CAS is believed to be
about three times higher than after CEA.2 The optimal
management of ISR has not yet been established yet.1,3e6
We report a new case of ISR, in which standard CEA with
stent removal was performed. We also performed a search
of the English literature in PubMed and Google Scholar.
Keywords used were (single word or combination): “carotid
endarterectomy”; “carotid artery stenting”; “in-stent reste-
nosis”; “restenosis”; and “recurrent stenosis”. Only patients
treated by CEA with stent removal due to ISR and reports
that contained adequate clinical information pertinent to
the analysis were included. Fifteen relevant articles were
found, four of which were excluded.
CASE REPORT
A 72-year-old, right-handed man presented with episodes
of right limb (both arm and leg) weakness and numbness of
1 month’s duration. Digital substraction angiography (DSA)
revealed 90% stenosis in the left internal carotid artery
(ICA) and 60% stenosis in the right ICA (Fig. 1A). He un-
derwent a left CAS with no complication (Fig. 1B). The
postprocedural treatment included atorvastatin and aspirin.
However, 8 months after CAS, he presented with recurrentrresponding authors. R. Wang and J. Zhao, Department of Neuro-
, Beijing Tiantan Hospital, Capital Medical University, 6 Tiantan Xili,
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://dx.doi.org/10.1016/j.ejvs.2013.10.011severe episodes of right limb weakness and numbness
(both arm and leg). He was referred to our hospital for
further treatment. On admission, a neurological examina-
tion revealed mild hemiparesis in the right limb. His past
history included hypertension and cigarette smoking, but he
had not smoked for 10 years. DSA showed severe ISR
(almost 99%) in the left ICA (Fig. 1C), and severe stenosis
(about 80%) in the right ICA.
A standard CEA with total removal of the stent was
performed. Endarterectomy proceeded in the usual way,
and no intense periarterial inﬂammation was present. The
traditional endarterectomy cleavage plane in the intima/
media layer was remarkably accessible. We cut the stent
into two pieces, and total removal of stent with the carotid
atheroma was achieved ﬁnally. The lumen of the ICA stent
was noted to be nearly completely ﬁlled with atheroscle-
rotic plaque and neointima (Fig. 2). The artery was closed in
a routine fashion without patch angioplasty.
The postoperative course was uneventful, and post-
operative computed tomography angiography revealed a
good result (Fig. 3). He was discharged home 7 days later in
good health. The postprocedural treatment included ator-
vastatin and aspirin. At the 2-month follow-up, he remained
asymptomatic without any evidence of recurrent restenosis.
DISCUSSION
Vale et al.4 reported the ﬁrst case of ISR successfully treated
by CEA with stent removal. We reviewed 41 cases of this
kind (Tables 1 and 2); 29 of them were symptomatic. We
tried to illustrate the safety, feasibility, and effectiveness of
this surgical management.
The ISR was typically diagnosed in old age (mean
age ¼ 65.9 years), and men were more frequently affected
(male:female ratio ¼ 2.1:1.0) (the sex of four patients was
not available and thus excluded from the analysis). Mean
interval between CAS and ISR was 13.7 months. ISR had
Figure 1. (A) Angiogram obtained before carotid artery stenting, showing a high grade stenosis of the left internal carotid artery (white
arrow). (B) Angiogram of the left carotid artery showing a mild stenosis after carotid artery stenting (white arrow). (C) Follow-up angiogram
obtained 8 months later revealing a pre-occlusive in-stent restenosis of the carotid stent (white arrow).
Figure 2. (A) The stent was enveloped by the plaque and neo-
intima. (B) Photograph showed cross-sectional views of plaque in
and around the stent. The lumen of the stent was noted to be
nearly completely ﬁlled with atherosclerotic plaque.
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most of these ISR are asymptomatic.2 The wide range in
reported ISR incidence may be a result of differences in the
deﬁnition of ISR used, the imaging tool, the duplex ultra-
sound (US) velocity criteria used, the duration of follow-up
and the type of stent implanted.7 US imaging was the most
commonly used technique to monitor carotid artery ste-
nosis after CAS. However, US velocity criteria for patients
after CAS were not well established.1 Lal et al.8 reported
that the presence of a stent in the carotid artery changed
the biomechanical properties of the artery. The enhanced
stiffness of the stentearterial wall complex was thought to
decrease the compliance of the vessel, leading to falsely
increased velocity.8 Higher grades of carotid artery reste-
nosis were estimated in a stented artery when velocity
criteria for native arteries are applied.1
The predominant mechanism leading to ISR was intimal
hyperplasia with smooth muscle cell proliferation.8 Patho-
logical examination of the specimen demonstrated intimal
hyperplasia in most of the cases.1,5,7,9,10 Some authors have
reported that stent implantation applied a transient strain
to the vessel wall activated smooth muscle cells, and
modulated a proliferative and inﬂammatory phase of vessel
repair.11 The inﬂammatory adhesion of the arteries to the
neighboring tissue might make the carotid artery exposure
difﬁcult,7 while the inﬂammatory reaction within the sten-
ted artery might cause the stent to become adherent to the
arterial wall, thus making stent removal difﬁcult.1 Vale
et al.4 hypothesized that atheromatous plaque persistence
may present as a mediator of a more advanced athero-
matous change or act as a stimulus for intimal hyperplasia
formation. Our patient demonstrated recurrent athero-
sclerotic plaque within the stent, which resulted in critical
luminal stenosis.
Figure 3. Postoperative computed tomography angiography
showed a mild stenosis after carotid endarterectomy with stent
removal (white arrow).
Table 1. Reported cases of in-stent restenosis (ISR) managed by stand
Reference Age
(y)/sex
ISR Interval Operation process
Vale et al.4 55/F 50% 6 mo Inﬂammation (N/A);
Calvey
and Gough6
45/M >70% 16 mo Inﬂammation (no); p
Reedy et al.13 49/M Severe 6 mo Inﬂammation (no); p
Reedy et al.13 54/M Severe 12 mo Inﬂammation (no); P
Akin et al.14 64/M 80% 17 mo Inﬂammation (N/A);
Setacci et al.12 82/M Severe 2 d Inﬂammation (N/A);
Setacci et al.12 78/M Occlusion 4 d Inﬂammation (N/A);
Jimenez et al.5 82/F 80e99% 8 y Inﬂammation (yes); p
King et al.15 53/M >70% 14 mo Inﬂammation (no); p
Jost et al.9 70/F Occlusion 2 h Inﬂammation (no); p
Jost et al.9 63/M 90% 12 wk Inﬂammation (no); p
Jost et al.9 80/F 80% 18 mo Inﬂammation (yes); p
Jost et al.9 81/F 90% 1 y Inﬂammation (yes); p
Present case 72/M 99% 8 mo Inﬂammation (no); p
Note. M ¼ male; F ¼ female; N/A ¼ not available; interval ¼ intervals
periarterial inﬂammation; plane ¼ intimaemedia plane; patch ¼ patch
10 J. Zheng et al.The optimal treatment strategy for ISR is yet to be
determined. Both endovascular therapy and surgical in-
terventions had been reported in the literature as suc-
cessful.3e5 Until now, no prospective studies have been
available to directly compare different techniques.
Vale et al.4 reported the ﬁrst case of ISR successfully
treated by standard CEA with stent removal. Since then,
only 41 cases of ISR have been treated using this surgical
method (Tables 1 and 2). The main reasons why surgeons
chose to perform endovascular therapy or other surgical
strategies instead of CEA are as follows: (1) carotid artery
dissection may be difﬁcult or even impossible owing to an
intense periarterial inﬂammatory process that may envelop
the vessels after CAS;3 (2) the inﬂammatory reaction within
the stented artery causes the stent to become adherent to
the arterial wall making identiﬁcation of the endarterec-
tomy plane very difﬁcult;10 (3) the use of a long stent makes
it difﬁcult to dissect out the entire stent4,10dsometimes it
might be impossible to safely gain proximal and/or distal
control of the common and internal carotid arteries;3,12 (4)
the difﬁculty involved in cutting the artery caused by the
metallic stent;4 and (5) the care required during removal of
the stent to avoid vessel wall penetration because of the
vessel wall thinning from the stent coils.4 Reichmann et al.1
published the largest series of patients (15), all of whom
underwent standard CEA with stent removal for ISR. There
were no signs of manifest periarterial inﬂammation. No
additional difﬁculties during the dissection phase were
encountered, and the stent and carotid plaque in all cases
could be completely removed as one single complex.1 de
Borst et al.10 reported similar ﬁndings. In this case series,
we found about 10.3% showed intense periarterial inﬂam-
mation (information regarding the periarterial inﬂammation
was not available for 12 cases; thus, they were excluded
from analysis), thus causing carotid artery exposure to be
much more difﬁcult than usual. Inﬂammation within theard carotid endarterectomy with stent removal.
Outcome Follow-up
plane (N/A) Uneventful Stable and no RR (6 wk)
lane (clear); patch Uneventful Stable and no RR (8 mo)
lane (clear); patch Uneventful N/A
lane (clear); patch Uneventful N/A
plane (N/A); patch Uneventful Stable (6 mo)
plane (N/A); patch Uneventful N/A
plane (N/A); patch Uneventful N/A
lane (clear); patch Uneventful Stable and no RR (4 mo)
lane (clear); patch Uneventful Stable and no RR (8 mo)
lane (N/A); graft Uneventful Stable and no RR (2 y)
lane (clear) Neck
haematoma
Stable and no RR (1 y)
lane (not clear); patch Uneventful Stable and no RR (6 mo)
lane (not clear); patch Aphasia,
dysphasia
Stable and no RR (6 mo)
lane (clear) Uneventful Stable and no RR (2 mo)
between carotid artery stenting and ISR; inﬂammation ¼ intense
angioplasty; graft ¼ graft interposition; RR ¼ recurrent restenosis.
Table 2. Reported cases of in-stent restenosis (ISR) managed by carotid endarterectomy with stent explantation.
Reference Included
patients
Mean
age (y)
ISR (%) Mean
interval
(mo)
Operation process Outcome Follow-up
de Borst et al.10 4 N/A 90e99 8.0 Inﬂammation (no); plane
(all clear); patch (4 cases)
Hemiparesis
(1 case); uneventful
(3 cases)
Stable and no RR
(mean follow-up
time ¼ 13 mo)
Raithel7 8 (M ¼ 6,
F ¼ 2)
68 80 6.0 Inﬂammation (N/A); plane
(N/A); patch (6 cases); graft
(2 cases)
Uneventful (8 cases) N/A
Reichmann
et al.1
15 (M ¼ 10,
F ¼ 5)
64.5 80 18.3 Inﬂammation (no); plane
(all clear); patch (13 cases)
Aphasia, hemiparesis
(1 case); neck
haematoma
(2 cases); uneventful
(12 cases)
Stable and no RR
(mean follow-up
time ¼ 21 mo)
Note. M ¼ male; F ¼ female; N/A ¼ not available; mean interval ¼ mean intervals between carotid artery stenting and ISR;
inﬂammation ¼ intense periarterial inﬂammation; plane ¼ intimaemedia plane; patch ¼ patch angioplasty; graft ¼ graft
interposition; RR ¼ recurrent restenosis.
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inﬂammation. Only 7.1% showed blurred intimaemedia
plane, which made dissection and stent removal difﬁcult.
Intimaemedia plane was clear in 92.9% (information
regarding the intimaemedia plane was not available in 13
cases; thus, they were excluded from the analysis). In most
cases, there were no additional difﬁculties in exposing the
ICA, and the traditional cleavage plane in the intima/media
layer was well recognizable and accessible, just like in our
patient.
Owing to the longer-length stent, it was difﬁcult to
dissect out the entire stent, so we cut the stent into two
pieces, and total removal of stent with the carotid
atheroma was ﬁnally achieved. Theoretically, the longer-
length stent may also make it more difﬁcult to obtain
cephalad control of the ICA. Hence, we must also express a
word of caution against using long stents, especially when
the distal tip of the stent is placed in a site difﬁcult to access
surgically. Although there was no peripheral nerve injury in
this cohort, identiﬁcation of the vagus and hypoglossal
nerves, which might be adherent to the arterial wall, must
also be made.5 Primary closure of the arteriotomy was
performed in ﬁve patients: three patients (7.3%) needed
graft interposition, and 33 arteriotomies (80.5%) were
closed with a venous or prosthetic patch. The results are
promising in these 41 cases. A good postoperative outcome
was achieved in 85.4% of cases (without ischemic events or
neck haematoma). In the early period after surgery, 7.3% of
patients presented with transient ischemic stroke; they fully
recovered several days later. A second operation owing to
neck haematoma, which might have been caused by the
antiplatelet therapy that was not stopped perioperatively,
was required in 7.3% of patients.1,9 No peripheral nerve
injury was found in this cohort. During a mean follow-up of
15.3 months, no adverse neurological events were re-
ported; all patients remained stable and without recurrent
restenosis (follow-up information of 12 patients was not
available; thus, they were excluded from the analysis).
Standard CEA with stent removal appears to be a safe,
feasible, effective, and durable therapeutic option.ACKNOWLEDGEMENTS
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